VolitionRx Limited (VNRX)


-0.01 (-0.77%)
Symbol VNRX
Price $0.77
Beta 1.680
Volume Avg. 0.18M
Market Cap 60.588M
Shares () -
52 Week Range 0.58-2.74
1y Target Est -
DCF Unlevered VNRX DCF ->
DCF Levered VNRX LDCF ->
ROE 12205.15% Strong Buy
ROA -187.70% Strong Sell
Operating Margin -
Debt / Equity -210.73% Sell
P/E -1.48 Sell
P/B -29.47 Strong Sell


Consensus EPS

Upgrades & Downgrades

Latest VNRX news

Mr. Cameron Reynolds MBA
Diagnostics & Research
American Stock Exchange

VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating samples for more accurate diagnosis; and Nu.Q Discover, a solution to profiling nucleosomes. The company operates Nucleosomics a technology platform for blood test. VolitionRx Limited is based in Austin, Texas.